PES1在疾病中的新兴作用:一个有前途的治疗目标?
Siyu Yuan1, Nuo Xu2, Jing Yang3
1Department of Pharmacology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
Gene
|August 29, 2024
概括
皮斯卡迪洛核糖体生物发生因子1 (PES1) 对于发育和核糖体生物发生至关重要. 过度表达的PES1驱动癌症和代谢疾病,呈现出潜在的治疗点.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 代谢疾病 代谢疾病
背景情况:
- 皮卡迪洛核糖体生物发生因子1 (PES1) 是一种核细胞蛋白质,对胚胎发育和核糖体合成至关重要.
- 过度表达PES1与各种癌症有关,促进瘤发生和进展.
- 在2型糖尿病 (T2DM) 和肥胖症中观察到升高的PES1水平,这表明它在代谢疾病的发病过程中发挥了作用.
研究的目的:
- 审查 PES1 的结构特征和生物功能.
- 总结PES1在癌症和代谢疾病中的作用,包括潜在的分子机制.
- 讨论将PES1作为治疗策略的临床潜力.
主要方法:
- 关于PES1结构,功能和疾病相关性研究的文献综述.
- 分析ESP1在瘤发生和代谢调节中的作用背后的分子机制.
- 评估目前关于PES1作为治疗点的研究.
主要成果:
- PES1通过增强细胞增殖,抑制衰老,调节瘤微环境 (TME) 和赋予耐药性来促进癌症.
- PES1通过调节脂质代谢,影响代谢疾病,特别是T2DM和肥胖症.
- PES1参与各种蛋白质复合体,有助于其多样化的功能.
结论:
- PES1是癌症和代谢疾病的关键因素,通过多个分子途径起作用.
- 向PES1为治疗癌症和代谢障碍提供了有前途的治疗潜力.
- 对PES1机制的进一步研究可能会导致新的临床干预措施.
相关概念视频
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
142
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
142
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
160
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
160
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K